Mandal P, Verma N, Chauhan S, Tomar RS
Cardiovascular Health: Improved blood pressure and reduced risk of major heart events
The completed study demonstrated significant efficacy with 45% clinical response in the AJM300 group versus 21% in placebo (OR 3.30, 95% CI 1.73-6.29, p=0.00028), good tolerability with similar adverse event rates between groups, and established AJM300 as a potential novel induction therapy for moderately active UC
Ways to Use Allulose Because allulose tastes so much like sugar, does not raise blood glucose, and provides potential health benefits, its a great option for ketogenic lifestyles
Retatrutides clinical performance is certainly noteworthy, but the next challenge extends beyond efficacy and into evidence translation, regulatory acceptance, and commercial scalability